Pacylex Pharmaceuticals Inc.
- | Biotech or pharma, therapeutic R&D
Pacylex Pharmaceuticals is a clinical stage oncology company pioneering a new class of anti-cancer compounds, NMT inhibitors. Pacylex is developing oral zelenirstat, the first in class NMTi, for heme cancers (Phase 2a) and has 27 other NMTis with single nM IC50s against human NMT1 for ADC Payloads.
Address
EdmontonCanada
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}